GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » argenx SE (NAS:ARGX) » Definitions » Net Margin %
中文

argenx SE (argenx SE) Net Margin % : -24.38% (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is argenx SE Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. argenx SE's Net Income for the three months ended in Dec. 2023 was $-99 Mil. argenx SE's Revenue for the three months ended in Dec. 2023 was $407 Mil. Therefore, argenx SE's net margin for the quarter that ended in Dec. 2023 was -24.38%.

The historical rank and industry rank for argenx SE's Net Margin % or its related term are showing as below:

ARGX' s Net Margin % Range Over the Past 10 Years
Min: -1475.28   Med: -198.08   Max: -24.03
Current: -24.03


ARGX's Net Margin % is ranked better than
66.76% of 1026 companies
in the Biotechnology industry
Industry Median: -163.08 vs ARGX: -24.03

argenx SE Net Margin % Historical Data

The historical data trend for argenx SE's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

argenx SE Net Margin % Chart

argenx SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -230.95 -1,475.29 -82.10 -172.76 -24.06

argenx SE Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -22.17 -13.17 -34.88 -22.03 -24.38

Competitive Comparison of argenx SE's Net Margin %

For the Biotechnology subindustry, argenx SE's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


argenx SE's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, argenx SE's Net Margin % distribution charts can be found below:

* The bar in red indicates where argenx SE's Net Margin % falls into.



argenx SE Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

argenx SE's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-295.053/1226.316
=-24.06 %

argenx SE's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-99.172/406.837
=-24.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


argenx SE  (NAS:ARGX) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


argenx SE Net Margin % Related Terms

Thank you for viewing the detailed overview of argenx SE's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


argenx SE (argenx SE) Business Description

Address
Laarderhoogtweg 25, Amsterdam, NH, NLD, 1101EB
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was approved in the U.S. in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.